Invention Grant
- Patent Title: Compositions and methods for inhibiting expression of CD274/PD-L1 gene
-
Application No.: US15906267Application Date: 2018-02-27
-
Publication No.: US10745704B2Publication Date: 2020-08-18
- Inventor: Antonin DeFougerolles , Tatiana Novobrantseva , Brian Bettencourt
- Applicant: ALNYLAM PHARMACEUTICALS, INC.
- Applicant Address: US MA Cambridge
- Assignee: ALNYLAM PHARMACEUTICALS, INC.
- Current Assignee: ALNYLAM PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Seed Intellectual Property Law Group LLP
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/04 ; C07H21/02 ; C12N15/113 ; A61K31/713
Abstract:
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the CD274/PD-L1 gene, and methods of using such dsRNA compositions to inhibit expression of CD274/PD-L1.
Public/Granted literature
- US20190048352A1 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE Public/Granted day:2019-02-14
Information query
